The Makers of the Omnipod® System
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod ® product platform. The Omnipod® Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod, by tailoring its Omnipod® technology platform for the delivery of non-insulin subcutaneous drugs across multiple therapeutic areas. Founded in 2000, more than 140,000 users across the globe rely on Insulet’s Omnipod ® Insulin Management System to bring simplicity and freedom to their lives.
Insulet Canada Corporation has proudly been serving Canadians since July, 7 2015 when it assumed direct distribution of the Omnipod® Insulin Management System, including sales, marketing, training and customer support activities. This has allowed Insulet to be closer to the diabetes community and further support Canadian customer needs over the long-term, as it does in the United States and Europe.
Media and Investor Inquiries
We would be happy to talk to your further. Please contact us via mail, phone, or email:
600 Technology Park Drive, Suite 200
Billerica, MA 01821
Corporate telephone: 1-978-600-7000
Corporate fax: 1-978-600-0120
From outside the US: 1-978-600-7850
Confidential customer fax: 1-877-467-8538
Canadian Customer Care: 1-855-POD-INFO (1-855-763-4636)
Investor inquiries email: firstname.lastname@example.org
Media inquiries in Canada email: email@example.com